More valuable than platinum: first-line pembrolizumab in advanced stage non-small-cell lung cancer

Ann Oncol. 2017 Apr 1;28(4):685-687. doi: 10.1093/annonc/mdx083.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Lung Neoplasms
  • Platinum*

Substances

  • Antibodies, Monoclonal, Humanized
  • Platinum
  • pembrolizumab